Nanjing King-friend Stock Hits Day Low Amid Price Pressure at CNY 7.90

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.59% as it reached an intraday low of CNY 7.90. This performance stands in contrast to the China Shanghai Composite, which fell by 3.05% on the same day. Over the past week, Nanjing King-friend has shown a positive trend, gaining 5.47%, but this is overshadowed by its one-year performance, which reflects a significant decline of 29.78%. The stock has consistently underperformed against the benchmark, with a three-year decline of 39.6% and a staggering 73.18% drop over the past five years. Financial metrics indicate that the company has faced challenges, with net sales growing at an annual rate of only 5.98% and operating profit declining by 4.37% over the last five years. The return on equity stands at 10.58%, and the company currently has a price-to-book ratio of 2.58. Despite a high dividend yield of 1.24%, the stock's long-term growth prospects appear limited, as evidenced by its recent negative results and underperformance relative to the broader market.